Skip to content
    Labcorp logo

    Labcorp

    Burlington, United StatesFounded 1978
    www.labcorp.comLinkedIn
    HealthcareBiotech & Life Sciences

    Labcorp is a global life sciences company headquartered in Burlington, North Carolina, providing laboratory diagnostics and drug development services. Through its corporate venture arm, the Labcorp Venture Fund, it invests in early-stage healthcare and life science companies driving innovative, data-driven, and personalized care.

    46% of their portfolio is in Healthcare. Deal activity increased 40% year-over-year (7 deals in the last 12 months). Average disclosed round size is $33.7M (across 58 rounds with reported amounts).

    Find people at Labcorp on Goldilocks AI

    Portfolio

    48

    Fund Size

    —

    Top Stage

    Series B

    Last 12 Mo

    7

    Team

    Jeffrey A. Davis

    Jeffrey A. Davis

    Director, Chair of the Audit Committee

    Kathryn E. Wengel

    Kathryn E. Wengel

    Director

    Kerrii B. Anderson

    Kerrii B. Anderson

    Director

    Kirsten M. Kliphouse

    Kirsten M. Kliphouse

    Director

    Paul B. Rothman, M. D.

    Paul B. Rothman, M. D.

    Director, Chair of the Quality and Compliance Committee

    Peter M. Neupert

    Peter M. Neupert

    Director

    Richelle P. Parham

    Richelle P. Parham

    Director, Chairperson of the Compensation and Human Capital Committee

    Victor Bulto

    Victor Bulto

    Director

    Amy Summy

    Amy Summy

    Executive Vice President, Chief Marketing Officer and Consumer Health Lead

    Brian Caveney

    Brian Caveney

    Executive Vice President and President, Biopharma Laboratory Services and Chief Medical and Scientific Officer

    Bryan Vaughn

    Bryan Vaughn

    Executive Vice President and President, Diagnostics

    Julia Wang

    Julia Wang

    Executive Vice President and Chief Financial Officer

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    63 investments
    CompanyRoundAmountDate
    Vitestro logoVitestroSeries B$70MMar 2026
    Prenosis logoPrenosisSeries A$20MJan 2026
    Precede Bio logoPrecede BioSeries B$63.5MJan 2026
    Cellens logoCellensSeed$6.5MDec 2025
    Emm logoEmmSeed$9MNov 2025
    Mercy BioAnalytics logoMercy BioAnalyticsSeries B$59MSep 2025
    MMercy BioSeries B$59MSep 2025
    IgniteData logoIgniteDataSeries A—Aug 2025
    PreciseDx logoPreciseDxUnknown$11MJun 2025
    Outcomes4Me logoOutcomes4MeSeries B$21MMay 2025
    Teal Health logoTeal HealthSeed$10MJan 2025
    Geneoscopy logoGeneoscopySeries C$105MJan 2025
    PreciseDx logoPreciseDxSeries B$20.7MAug 2024
    PPreciseDxSeries B$20.7MAug 2024
    NowDx logoNowDxSeries B$22.5MJul 2024
    Phenomix Sciences logoPhenomix SciencesSeries A$5.5MMay 2024
    Acclinate logoAcclinateSeries A$7MMay 2024
    Vitestro logoVitestroSeries B$22MApr 2024
    Praia Health logoPraia HealthSeries A$20MApr 2024
    Prolocor logoProlocorBridge$1.7MJan 2024
    Acclinate logoAcclinateSeries A$7MJan 2024
    Evvy logoEvvySeries A—Sep 2023
    Adela logoAdelaSeries B$48MSep 2023
    Vital Bio logoVital BioSeries B$48MJul 2023
    Vital Bio logoVital BioSeries A—Jul 2023
    Page 1 of 3

    Top Co-Investors

    Merck Global Health Innovation Fund7 shared
    Alexandria Venture Investments6 shared
    UPMC Enterprises5 shared
    Northpond Ventures4 shared
    Sozo Ventures4 shared
    Portfolia4 shared
    iSelect Fund4 shared
    Bristol Myers Squibb3 shared
    Deerfield3 shared
    Perceptive Advisors3 shared
    Eventide Asset Management3 shared
    Emerson Collective3 shared
    Woori Venture Partners3 shared
    Corewell Health Ventures3 shared
    8VC2 shared
    Inovia Capital2 shared
    General Catalyst2 shared
    F-Prime Capital2 shared
    Decheng Capital2 shared
    Fidelity Investments2 shared

    Last updated: 7 October 2026